FindTrial
Sign In

Multimodal Intelligent Screening and Risk Early Warning for High Myopia: A Cohort Study

Multimodal Imaging and AI-Driven Precision Diagnosis and Treatment of High Myopia: Cohort Construction and Identification of Imaging Biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117930
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Myopia

Interventions

Moderate Myopia Group:None
Healthy Group:None
Low Myopia Group:None
High Myopia Group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Able to cooperate with visual acuity, refraction, fundus imaging examinations, and necessary questionnaire surveys or biological sample collection; 2. Voluntarily participate in the study and sign the informed consent form (signed by guardians for minors); 3. Accept the follow-up procedures specified in this study.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate with follow-up or study-related examinations and operations; 2. The quality of collected clinical, imaging and other data does not meet the research requirements; 3. Females who are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Spherical Equivalent Refraction;Occurrence of High Myopia Complications;—

Countries

China

Contacts

Public ContactLiu Xinting

Eye Hospital, Wenzhou Medical University

liuxt@eye.ac.cn+86 577 8806 8821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026